GlassScriptPhysician profile
Philip J Rubinfeld
NPI 1629074091
$3,828.86
in general payments reported to CMS, 2019-2025
43 companies · $968 in 2025
The $968 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $493 · 2020: $530 · 2021: $378 · 2022: $464 · 2023: $394 · 2024: $601 · 2025: $968.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,964.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,963.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $684.43 | 2019-2025 | Xtampza |
| Biotronik Nro, INC. | $448.25 | 2025 | Prospera |
| Abbvie INC. | $392.30 | 2021-2025 | Qulipta, Ubrelvy |
| Medtronic, INC. | $242.57 | 2022-2025 | Intellis Adaptivestim, Inceptiv |
| Arbor Pharmaceuticals, INC. | $205.39 | 2019-2022 | |
| Boston Scientific Corporation | $183.82 | 2019-2025 | Wavewriter Alpha Prime 16, General - Pain Management |
| Nevro Corp. | $180.37 | 2020-2024 | Senza |
| Centinel Spine, LLC | $180.06 | 2020 | |
| Abbott Laboratories | $139.44 | 2022-2025 | Proclaim, Eterna |
| Vertiflex, INC. | $118.33 | 2019 | |
| Daiichi Sankyo INC. | $112.06 | 2019 | |
| Lilly USA, LLC | $65.08 | 2019-2021 | |
| Pfizer INC. | $64.54 | 2020-2021 | |
| Ibsa Pharma INC. | $51.31 | 2021-2024 | Tirosint, Licart |
| Kowa Pharmaceuticals America, INC. | $49.85 | 2022 |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Philip Rubinfeld listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.